NCT05698004 is a NA clinical trial of prone positioning in Respiratory Failure, ICU, sponsored by Montaser Gamal Ahmed.

Who is sponsoring NCT05698004?

NCT05698004 is sponsored by Montaser Gamal Ahmed.

What drugs are being tested in NCT05698004?

Interventions in NCT05698004: prone positioning.

What condition does NCT05698004 study?

NCT05698004 studies Respiratory Failure, ICU.

Is NCT05698004 still recruiting?

NCT05698004 is currently status unknown. Last updated 26 January 2023.

Last reviewed 2023-01-26 · How we verify

NCT05698004

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Wake Prone Positioning in Non-intubated Patients With Acute Hypoxemic Respiratory Failure

Status unknown NA Last updated 26 January 2023

What this trial tests

NA trial testing prone positioning in Respiratory Failure, ICU in 244 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
1 January 2024

1 April 2024

Quick facts

Lead sponsor	Montaser Gamal Ahmed
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	244
Start date	1 February 2023
Primary completion	1 January 2024
Estimated completion	1 April 2024

Drugs / interventions tested

prone positioning

Conditions studied

Respiratory Failure, ICU — all drugs for Respiratory Failure, ICU →

Sponsor

Montaser Gamal Ahmed

Who can join

18 and older, any sex, with Respiratory Failure, ICU. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients admitted to the ICU with severe hypoxemia are at high risk for mortality. Few therapies have been proven to improve patient outcomes or duration of mechanical ventilation e.g. low tidal volume ventilation, prone positioning, and a fluid-restrictive strategy. Prone positioning is a technique used to help patients with acute respiratory distress syndrome breathe better. There is high degree of uncertainty on its effects on clinical outcomes in non-intubated patients with acute hypoxemia and larger studies are needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of prone positioning

Trials testing the same drug.

NCT06530095 — We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hour · completed
NCT05008380 — Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 Pneumonia · NA · completed

Other recruiting trials for Respiratory Failure, ICU

Currently open trials in the same condition.

NCT07030413 — Weaning From High Flow Nasal Oxygen in Acute Respiratory Failure : a Target Trial Emulation · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05698004 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Montaser Gamal Ahmed
Last refreshed: 26 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05698004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing